We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance ROCKVILLE, MD, November 6, 2024 — MaxCyte, Inc. (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering...
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.06 | -1.72413793103 | 3.48 | 3.48 | 3.18 | 300 | 3.33 | DE |
4 | 0.2 | 6.21118012422 | 3.22 | 3.48 | 3.18 | 233 | 3.31428571 | DE |
12 | -0.02 | -0.581395348837 | 3.44 | 3.58 | 3.18 | 314 | 3.4088668 | DE |
26 | -1.16 | -25.327510917 | 4.58 | 4.66 | 3.18 | 269 | 3.66002857 | DE |
52 | -1.1399999 | -24.9999983553 | 4.5599999 | 4.66 | 3.18 | 327 | 4.0206462 | DE |
156 | 1.04 | 43.6974789916 | 2.38 | 4.66 | 2.38 | 489 | 3.68027663 | DE |
260 | 1.04 | 43.6974789916 | 2.38 | 4.66 | 2.38 | 489 | 3.68027663 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions